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Cellular processes often depend on stable physical
associations between proteins. Despite recent
progress, knowledge of the composition of human
protein complexes remains limited. To close this
gap, we applied an integrative global proteomic
profiling approach, based on chromatographic sepa-
ration of cultured human cell extracts into more than
one thousand biochemical fractions that were subse-
quently analyzed by quantitative tandemmass spec-
trometry, to systematically identify a network of
13,993 high-confidence physical interactions among
3,006 stably associated soluble human proteins.
Most of the 622 putative protein complexeswe report
are linked to core biological processes and encom-
pass both candidate disease genes and unannotated
proteins to inform onmechanism. Strikingly, whereas
larger multiprotein assemblies tend to be more
extensively annotated and evolutionarily conserved,
human protein complexes with five or fewer subunits
are far more likely to be functionally unannotated or
restricted to vertebrates, suggesting more recent
functional innovations.
INTRODUCTION
Protein complexes are stable macromolecular assemblies that
perform many of the diverse biochemical activities essential to
cell homeostasis, growth, and proliferation. Comprehensive
characterization of the composition of multiprotein complexes
in the subcellular compartments of model organisms like yeast,1068 Cell 150, 1068–1081, August 31, 2012 ª2012 Elsevier Inc.fly, worm, and bacteria have provided critical mechanistic
insights into the global modular organization of conserved bio-
logical systems (Hartwell et al., 1999), accelerated functional
annotation of uncharacterized proteins via guilt by association
(Hu et al., 2009; Oliver, 2000), and facilitated understanding of
both evolutionarily conserved and disease-related pathways
(Vidal et al., 2011). How the 20,000 or so proteins encoded
by the human genome are partitioned into heteromeric ‘‘protein
machines’’ remains an important but elusive research question,
however, as less than one-fifth of all predicted human open
reading frames are currently annotated as encoding subunits
of protein complexes in public curation databases (Ruepp
et al., 2010).
Loss-of-function mutations in genes encoding the subunits of
protein complexes typically give rise to similar phenotypes or,
through genetic interaction, amplify the phenotypic effects
of other alleles in functionally linked sets of genes. Identifying
the membership of protein complexes, therefore, addresses a
crucial layer in the hierarchical functional organization of biolog-
ical systems that links the core biochemistry of a functioning
cell to the general physiology of an organism and is fundamental
to deciphering the relationship between genotype and pheno-
type.Althoughbioinformatics analyseshavebeenused topredict
evolutionarily conserved human protein-protein interactions
(PPIs) on a large scale (Ramani et al., 2008; Rhodes et al., 2005),
most of these associations remain to be verified experimentally.
Affinity purification (AP) of tagged exogenous proteins
coupled with tandem mass spectrometry (MS) is an effective
method for isolating and characterizing the composition of stably
associated human proteins in experiments ranging from dozens
to hundreds of different ‘‘baits’’ (Behrends et al., 2010; Bouw-
meester et al., 2004; Ewing et al., 2007; Hutchins et al., 2010;
Jeronimo et al., 2007; Mak et al., 2010; Sardiu et al., 2008;
Sowa et al., 2009). Likewise, immunoprecipitation can be used
to systematically isolate endogenous human protein complexes
from human cell lines (Malovannaya et al., 2011). Nevertheless,
the limited availability of high-quality antibodies or sequence-
verified complementary DNA (cDNA) clones suitable for targeted
protein complex enrichment precludes scale-up required for the
unbiased assessment of the molecular association networks
underlying human cells. Hence, despite considerable successes
in the comprehensive identification of protein complexes in
model organisms (Butland et al., 2005; Gavin et al., 2002,
2006; Guruharsha et al., 2011; Ho et al., 2002; Hu et al., 2009;
Krogan et al., 2006; Ku¨hner et al., 2009), clone-based protein
purification techniques remain challenging for proteome-scale
studies of physical interaction networks in mammalian cells.
Conversely, although traditionally used to isolate discrete
complexes with specific assayable biochemical properties
(e.g., enzymatic activity), classical biochemical fractionation
procedures have been used to resolve biological mixtures as
a means of ascertaining the collective composition of human
protein complexes present in certain subcellular compartments
(Ramani et al., 2008; Wessels et al., 2009).
Here, we have combined extensive, scaled-up biochemical
fractionation with in-depth, quantitative mass spectrometric
profiling and stringent computational filtering to resolve and
identify endogenous, soluble, stably associated human protein
complexes present in cytoplasmic and nuclear extracts gener-
ated from cultured cells. Although the resulting reconstructed
high-quality physical interaction network shows strong overlap
with existing curated and experimentally derived sets of anno-
tated protein complexes, it contains many predicted subunits
and previously unreported complexes with specific functional,
evolutionary, and disease-related biological attributes. To our
knowledge, this resource represents the largest experimentally
derived catalog to date of human protein complexes from cell
culture, measured using a single standardized assay, and a reli-
able first draft reference of the basic physical wiring diagram of
a human cell.
RESULTS
High-Throughput Complex Fractionation and Detection
by Tandem Mass Spectrometry
To isolate human protein complexes in a sensitive and unbiased
manner, we subjected cytoplasmic and nuclear soluble protein
extracts isolated from human HeLa S3 and HEK293 cells grown
as suspension and adherent cultures, respectively, to extensive
complementary biochemical fractionation procedures. These
two widely studied laboratory cell lines have been used as
models of human cell biology for many decades (Graham
et al., 1977; Masters, 2002), providing a rich biological context
for interpreting the resulting proteomic data. Stably interacting
proteins that cofractionated together were identified subse-
quently by nanoflow liquid chromatography-tandemmass spec-
trometry (LC-MS/MS). We optimized our entire experimental
pipeline, illustrated schematically in Figure 1A, by using a multi-
pronged strategy to minimize two major confounding issues:
limited dynamic range (i.e., preferential detection of high-abun-
dance components) and ‘‘chance’’ coelution (i.e., cofractiona-
tion of functionally unrelated proteins).To address the former concern, we performed extremely deep
biochemical fractionations by employing multiple orthogonal
separation techniques to better resolve distinct protein com-
plexes. As a primary separation technique, we employed nonde-
naturing high-performance multibed ion exchange chromatog-
raphy (IEX-HPLC) by using four different empirically optimized
analytical column combinations (see Experimental Procedures)
and shallow salt gradients unlikely to perturb nonionic protein
associations (Havugimana et al., 2007). In parallel, we applied
complementary sucrose gradient centrifugation and isoelectric
focusing technologies to capture salt-sensitive protein assem-
blies. In total, we collected 1,163 different fractions in a total of
eight nuclear and five cytosolic extract fractionation experiments
(for details see Table S1 available online), which were each sub-
jected to label-free shotgun sequencing (duplicate LC-MS/MS
analyses) using highly sensitive ion trap-based mass spectro-
meters (see Experimental Procedures).
We identified 5,584 distinct human proteins (Figure 1C; esti-
mated theoretical false discovery rate of 1% at both the protein
and peptide levels based on a statistical model [Kislinger et al.,
2003]; see Experimental Procedures for details). Despite the
underrepresentation of membrane proteins in the starting cell
extracts, this coverage encompasses about half of the experi-
mentally verified human proteome (Figure S1B) (Nagaraj et al.,
2011). This included 989 proteins detected exclusively in nuclear
fractions (of which 376 were annotated transcription or chro-
matin-related factors) and 1,006 with links to human disease
(e.g., annotated in a public database like OMIM). Only 1,632
(29%) of the identified proteins had biochemical annotations as
subunits of previously reported protein complexes (correspond-
ing to 64% of all existing human protein entries) in the CORUM
curation database (Figure S1C; Ruepp et al., 2010). Due to the
extensive fractionation, we observed minimal bias in terms of
protein abundance beyond that reported for previously anno-
tated complexes or the experimentally defined human proteome
(Figure 1D).
Next, to minimize the possibility of chance coelution, rather
than simply identifying the proteins present in each fraction,
we quantified variation in protein abundance based on the
observed patterns of spectral counts recorded across all of the
collected fractions to determine the extent to which pairs of
proteins coeluted. As shown in Figure 1B, these experimental
profiles were highly reproducible (i.e., average Spearman rank
correlation coefficients >80% between replicate experiments;
Figure S2), even using alternate methods of mass spectrometric
quantification (i.e., extracted MS1 peak intensities were largely
consistent with spectral counting; Figure S2D). To objectively
evaluate the biochemical data, we calculated a stringent
summary statistic, termed the coapex score, for each pair of
proteins identified by LC-MS/MS by determining the number
of fractionation experiments in which the proteins showed
maximum (modal) abundance in the same exact peak fraction.
To assess the effectiveness of our cofractionation approach,
we performed an initial validation by examining the coelution
profiles and coapex scores obtained for a reference set of 20
well-known human protein complexes reported in CORUM. As
illustrated by the representative HeLa nuclear extract IEX-
HPLC profiles shown in Figure 1B, the subunits of theseCell 150, 1068–1081, August 31, 2012 ª2012 Elsevier Inc. 1069
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Figure 1. Integrative Cofractionation Strategy Used to Identify Human Soluble Protein Complexes
(A) Cell extracts were extensively fractionated using different biochemical techniques (IEX, ion exchange chromatography; IEF, isoelectric focusing; SGF, sucrose
density gradient centrifugation). Coeluting proteins were identified by mass spectrometry, and a coelution network was generated by calculating profile similarity
(see Extended Experimental Procedures).
(B) Cofractionation (IEX-HPLC) profiles of annotated subunits of 20 representative human protein complexes from HeLa nuclear extract. Shading indicates
normalized spectral counts (SPC). Peak apex and adjacent peaks are shown.
(C) Hierarchical clustering of 5,584 proteins identified by LC-MS/MS.
(D) Protein abundance levels corresponding to components of our identified coeluting proteins (red line), reconstructed complexes (blue), or annotated CORUM
complexes (black) estimated from the reported HeLa proteome (Nagaraj et al., 2011).
See also Figure S1 and Table S1.complexes typically coeluted in the same biochemical fractions.
Of the 155 components detected by mass spectrometry, most
(85%; 499/585) of the detected subunit pairs of the reference
complexes had high coapex similarity scores (i.e., coeluted
together in at least two ormore experiments), validating the over-
all efficacy of the fractionation procedures we used to isolate
native protein complexes and the general correctness of the
protein identification and quantification pipeline.
Reconstruction of a High-Confidence Cocomplex
Interaction Network
Despite the consistency in coelution of annotated complex
members, certain functionally distinct complexes occasionally1070 Cell 150, 1068–1081, August 31, 2012 ª2012 Elsevier Inc.exhibited overlapping chromatographic elution profiles (e.g.,
splicing factor 3b andCoatomer complexes; Figure 2A), present-
ing a potential source of spurious interactions. Although this arti-
fact was minimized to a certain degree by performing multiple
independent fractionation experiments, we used an integrative
computational approach to further improve deconvolution (Fig-
ure 2B). Because physically interacting cocomplexed proteins
often perform related biological functions (Alberts, 1998) and
are often evolutionarily coconserved (Hartwell et al., 1999), we
devised a machine learning procedure (Figure 2B; see Experi-
mental Procedures for details) to score and select higher-confi-
dence physical interactions based on both the experimentally
measured coelution profiles and the existence of additional
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Figure 2. Denoising the Biochemical Coelution Network and Generation of High-Confidence Physical Interactions
(A) Biochemical cofractionation network of 20 reference complexes with coelution coapex scoresR2. Nodes represent protein subunits (colors reflect complex
membership), whereas edges represent interactions (thickness proportional to the number of shared coapexes).
(B) The biochemical data were combined with weighted functional association evidence by using a Random Forest classifier and a training set of reference
complexes (CORUM) to filter out spurious connections and to infer a high-confidence interactome. The PPI and predicted clusters were evaluated with inde-
pendent functional criteria to ensure high quality. Arrows represent data flow, blue diamonds are attributes in the decision tree vector, and green diamonds (leafs)
are the final result (positive or negative).
(C) Cumulative precision-prediction rank curves for the LC-MS/MS data alone and after integration with genomic evidence. Incorporation of the functional
evidence increased both precision (reduced false positives) and recall (more true positives).
(D) Network of 20 reference complexes after filtering with functional evidence.
(E) Overall correlation (Spearman r = 0.40; n = 11,675) of our scored human PPI with corresponding interaction scores reported for orthologous fly PPI fromwhich
validated, high-confidence complexes were derived (Guruharsha et al., 2011). Heatmap shows prediction accuracy (log ratio of CORUM reference positives to
negatives), with high-scoring pairs in both studies highly enriched for positives.
(F) Precision-recall curve showing performance obtained after denoising reconstructing withheld reference CORUM complexes highlighted by red dots at the
threshold at which half of the protein pairs per complex are recovered.
See also Figure S5 and Table S2.supporting functional association evidence inferred from
correlated evolutionary rates (Tillier and Charlebois, 2009)
and functional genomics data sets compiled for H. sapiens,
S. cerevisiae, D. melanogaster, and C. elegans (see Table S6
for details).
First, for each of the 13 fractionation experiments, we calcu-
lated correlation measures between all possible pairs of proteins
to capture their tendency to coelute. In addition to the coapexsummary statistic, to account for mass spectrometry sampling
error, we devised a weighted cross-correlation function to
account for slight variation in the protein profiles measured in
each experiment. To account for low spectral values, we also
generated a Poisson noise model before calculating Pearson
correlation scores, deeming the coelution profiles of protein
pairs measured with low spectral counts as less predictive of
genuine physical interactions (Figure S5). Only protein pairsCell 150, 1068–1081, August 31, 2012 ª2012 Elsevier Inc. 1071
with a correlation score of at least 0.5 by at least one of these
measures in one or more experiments were considered for
further analysis, reducing the total number of pairs from over
15 million initially to the roughly 800,000 pairs with reasonable
biochemical evidence.
To improve the assignment of interaction probabilities, we also
exploited the predictive power of correlated protein evolutionary
rates (Tillier and Charlebois, 2009), messenger RNA (mRNA)
coexpression, and domain co-occurrence and, via orthology,
fly protein-protein interactions (based on binary yeast two-hybrid
assay studies) and extensive physical and functional associa-
tions reported previously for yeast and worm (see Experimental
Procedures) (Lee et al., 2011). The discriminatory power of the
procedure was further improved by penalizing those interactions
that lacked independent supporting evidence—and that were
thus more likely to correspond to cases of ‘‘chance’’ coelu-
tion—by integrating evidence from these functional association
data (Figure 2B). A feature selection algorithmwas used to select
the most informative data sets (Table S2) in addition to the
biochemical correlation scores, and the resulting features were
used to estimate the probability of interaction to protein pairs
using a cross-validated random forest classifier.
For training, we used the CORUM curated set of human
protein complexes as our base reference, filtered for those
complexes annotated as having been observed by biochemical
methods. As many CORUM complexes are highly overlapping
due to redundancy in existing annotations, we combined
complexes sharing subunits (Simpson coefficient >0.5 between
complexes). We used half of the resulting 324 nonredundant
reference complexes (Table S3) as the training set for cocomplex
probability prediction, defining gold standard positive interac-
tions as pairs of proteins in the same complex and inferring
gold standard negatives between proteins in different
complexes. (The other half of the reference complexes was with-
held for subsequent use as an independent training set for
cluster optimization, as described below.)
Although the biochemical data were a prerequisite for scoring,
the performance curves shown in Figure 2C indicate that the
inclusion of the additional functional genomic information
substantially increased recall at the same level of precision
compared to classifiers based on the profiling data alone. More-
over, the integration of this additional supporting functional
evidence removed the bulk of spurious, intercomplex interac-
tions (Figure 2D). Another advantage of our bioinformatic pipe-
line is that the results of the feature selection algorithm (Table
S2) can be explored to examine the impact of each data set.
For example, we find generally that sets of smaller biochemical
fractionations using different separation techniques, although
individually yielding a higher PPI false discovery rate, collectively
providedmore information on protein complex composition than
deeper fractionations using a single separation method.
As an alternatemeasure of reliability, we compared our scored
human protein interactions to a recently reported network of
Drosophila cocomplex protein interactions (Guruharsha et al.,
2011), which had not been used for building the classifier. Strik-
ingly, despite using vastly different experimental methods and
scoring schemes, we observed a remarkably good overall corre-
lation (Spearman r = 0.40; n = 11,675 orthologs mapped using1072 Cell 150, 1068–1081, August 31, 2012 ª2012 Elsevier Inc.Inparanoid). Even after removing interactions supported by
alternate Drosophila data, high-scoring fly pairs matched high-
scoring pairs in our analysis and were strongly enriched for
reference-positive cocomplex members (Figure 2E).
Finally, in order to remove any remaining false positive interac-
tions, we further denoised our cocomplex data set by pruning
loosely connected interactions using a computational diffusion
procedure calibrated by protein colocalization semantic simi-
larity scores (Pesquita et al., 2009; Yang et al., 2012) to enforce
local network topologies more consistent with annotated
complexes from the withheld portion of the reference Corum
complexes (see Experimental Procedures). Benchmark preci-
sion and recall versus the holdout set of known reference
complexes (Figure 2F) were significantly higher than those re-
ported for a smaller, recently published set of affinity-purified
human protein complexes (Hutchins et al., 2010), validating the
reliability of our scoring procedure.
Applying a PPI score threshold of 0.75, which corresponds to
an estimated false discovery rate of 21.5% (i.e., well below the
40% reported for AP/MS-based analyses of protein complexes
in model organisms [Gavin et al., 2006; Krogan et al., 2006;
Ku¨hner et al., 2009]), we thus derived a high-confidence set of
13,993 cocomplex interactions among 3,006 unique human
proteins (Table S2), most of which (8,691 PPI) have not been
reported before (i.e., are not publicly annotated). It is worth reit-
erating that all of these physical interactions were directly sup-
ported by the experimental biochemical cofractionation data;
the addition of functional data and denoising served only to
flag candidates lacking either functional support or topological
support within the network (Table S2). The interaction probability
scores may be underestimated, however, because the reference
‘‘gold standards’’ used for learning are imperfect (Jansen and
Gerstein, 2004).
Construction and Validation of Protein Complexes
from the Probabilistic Interaction Network
In order to define complex membership, we partitioned the high-
confidence probabilistic physical interaction network by using
the cluster growth algorithm ClusterONE (Nepusz et al., 2012),
which outperformed other clustering methods on the denoised
PPI network (Table S5). In total, the clustering predicts 622
discrete putative complexes encompassing 2,634 distinct
proteins (Table S3). Complex membership size distribution
approximated an inverse power law with a median of four
subunits (Figure S4A). The majority (62%; 385/622) of the
complexes have not been annotated (i.e., only 237 are currently
curated in a public database like CORUM; Figures 3A and 3C).
Although the fraction of curated components varies, we also
recapitulated 258 previously reported complexes (Figure 3C),
including several well-known membrane-associated com-
plexes, such as the coat protein I and II (COPI/II) vesicle transport
complexes that shuttle cargo between the Golgi and endo-
plasmic reticulum. Strikingly, most (67%; 335) of the 500 smaller
putative complexes with five or fewer components, including the
bulk (74%; 83) of the 112 predicted heterodimers, have never
been curated before (Figure 3C).
Both independent experimental validation based on more tra-
ditional immunoprecipitation or coaffinity purification methods
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Figure 3. Global Validations of the Map of High-Confidence Human Protein Complexes
(A) Complex size distribution of the 622 inferred complexes.
(B) Network of predicted human protein complexes proportioned according to subunit number and displaying existing curations, validation status by AP/MS
(Malovannaya et al., 2011), and PPI connectivity (proportioned edge width).
(C) Proportions of annotated complexes in public repositories (CORUM, PINdb, REACTOME, and HPRD) or independently experimentally verified.
(D) Enrichment analysis showing overlap with large-scale APMS data sets generated for human (Hutchins et al., 2010; Malovannaya et al., 2011) and
(via orthology) fly (Guruharsha et al., 2011).
See also Table S3.and orthology mapping support at least 21 of these putative
complexes (i.e., not in any reference database) (Table S3; see
Supplemental Information for details). For example, Guruharsha
et al. (2011) recently reported 299 cocomplex interactions based
on pull-down experiments of 43 affinity-tagged human proteins
present in 41 of our complexes, of which 143 interactions map
precisely to our predicted complexes, representing a 47.8% vali-
dation rate (which may be an underestimate, as Guruharsha
et al. [2011] do not report human interactions that fall outside
the fly interologs examined in their study). Likewise, the results
of Malovannaya et al. (2011), who used large-scale immunopre-
cipitation to isolate native human protein complexes, show
excellent agreement to 123 of our complexes (i.e., Benjamini-
corrected hypergeometric p % 0.05), including 42 (34%) of our
complexes that are not curated in CORUM (Figure 3B and Table
S3). Figure 3D summarizes the highly significant overlap of our
inferred complexes with these fully independent data sets, with
enrichments ranging from 4- to 477-fold more than chance,thus broadly and systematically validating our network of derived
human protein complexes.
By design, insoluble membrane-associated (hydrophobic)
protein complexes were largely missed in this study, and the
proteins assigned to complexes had a higher average transcript
abundance (Figures S2A and S2B). Moreover, in an effort to
control the false positive rate, our conservative clustering algo-
rithm, ClusterONE, underweighted small clusters of size 2 or 3
for lack of sufficient association evidence, likely contributing to
the prominence of complexes with four subunits in Figure 3A.
But we did not observe any significant bias toward negative
(pI % 7) or positive (pIR 7) charge as compared to complexes
curated in CORUM (Figure S4B).
Figure 4 shows the broad functional diversity of the predicted
complexes (a navigable map is available online for close visual-
ization of individual clusters and their supporting cocomplex
interactions). Consistent with biological expectation (Hartwell
et al., 1999; Lage et al., 2007; Oliver, 2000; Vidal et al., 2011),Cell 150, 1068–1081, August 31, 2012 ª2012 Elsevier Inc. 1073
Figure 4. Global Map of High-Confidence Human Protein Complexes
(A) Schematic of the global network of inferred human soluble protein complexes (colored by membership) with representative examples and supporting PPI
highlighted.
(B) Putative complexes with two or more components with human disorder associations annotated in UniProt (UniProt Consortium, 2011), Online Inheritance
of Man (OMIM) (Hamosh et al., 2005), or the Genetic Association Database (GAD) (Becker et al., 2004). Inset table shows highly significant interaction overlap
1074 Cell 150, 1068–1081, August 31, 2012 ª2012 Elsevier Inc.
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Figure 5. Membership in Complexes
Predicts Protein Function and Disease
Associations
(A) Three of four proteins mapped to the cohesin
complex account for roughly half of cases of the
human congenital disorder Cornelia de Lange
syndrome (Pie´ et al., 2010), implicating the fourth
component, RAD21, as a candidate disease gene.
This association may explain similarities in clinical
presentation between CdLS and Langer-Giedion
syndrome, as the latter patients routinely harbor
RAD21 deletions, e.g., McBrien et al. (2008) and
Wuyts et al. (2002).
(B) Confirmation of ribosome biogenesis
candidate (orange) associations with annotated
components (blue) by AP/MS analysis of tagged
proteins (top). Colored squares indicate validation
(see Extended Experimental Procedures).
(C) Polysome profiling after siRNA targeting in
tissue culture supports functional roles in ribo-
some biogenesis for three candidate proteins.
Knockdown of MKI67IP, FTSJ3, and, to a lesser
extent, GNL3, results in 60S ribosomal subunit
biogenesis defects manifested by a reduced
ratio of free 60S to 40S ribosomal subunits during
gradient sedimentation as compared to control.
Percentages indicate siRNA knockdown effi-
ciency as measured by qRT-PCR.the subunits of the complexes were significantly enriched for
related biological functions, transcriptional regulatory motifs,
and pathological processes (Figure 4B, inset table). Compared
to the entire set of identified proteins, the clustered proteins
also showed enrichment for posttranslation modifications
linked to cellular regulation, like acetylation (Benjamini-corrected
p % 1041) and phosphorylation (p % 105). Many of the
complexes are linked to core cellular processes, such as
mRNA splicing (p% 1015) or transcription (p% 105), that either
are essential in human (p % 10138) or that have RNA interfer-
ence (RNAi)-induced phenotype in cell culture (e.g., cell division
arrest, p % 1031) or are associated, via orthology, with similar
mouse, yeast, or worm mutant phenotypes (Figure 4B, inset
table; see Table S4 for details).(i.e., shared annotated edges) with phenotypic data sets that reveals that protein subunits of the same predic
and genetic associations in human populations (see Extended Experimental Procedures), RNAi phenotypes in
RNAi phenotypes in other species (via orthology), and shared transcriptional regulatory motifs (Xie et al., 200
See also Figure S4C and Table S4.
Cell 150, 1068–1081,Clinical and Biological Implications
of the Reconstructed Human
Protein Complexes
Consistent with this strong tendency for
proteins in the same complex to be affili-
ated with similar mutational and RNAi
phenotypes, subunits of the predicted
human protein complexes were much
more likely than chance (p % 1046) to
have links to a documented clinical
pathology (Figure 4B; see Table S4 fordetails), with disease-associated proteins distributed broadly
among the complexes (Figures 4B and S4C). Closer examination
of the interaction subnetworks—comprising known human
disease genes with genes that currently lack annotation or that
have not previously been associated with any human disorders
(Figure 4B)—highlights the utility of the map.
One such example is shown in Figure 5A, illustrating the case
of the human developmental disorder Cornelia de Lange
syndrome (CdLS). Mutations in three subunits of the cohesin
complex (SMC1A, SMC3, and NIPBL) have been linked to
CdLS (Pie´ et al., 2010), implicating an additional component
(RAD21) as a candidate CdLS locus, and are consistent with at
least one unmapped CdLS locus residing on chromosome 8
(DeScipio et al., 2005). The link to RAD21 provides a likelyted human complex tend to exhibit similar disease
cell culture (Neumann et al., 2010), mutational and
5).
August 31, 2012 ª2012 Elsevier Inc. 1075
explanation for the occasional overlap of Langer-Giedion
syndrome (LGS) clinical presentation with CdLS, as all LGS
patients are at least partially defective for RAD21 (see e.g.,
McBrien et al., 2008; Wuyts et al., 2002). Similarly, RAD18,
a homolog of SMC3 and SMC1A, may play a role in CdLS that
is consistent with unmapped CdLS deletions within chromo-
some 3p25 (DeScipio et al., 2005). Reports coinciding with the
preparation of this manuscript confirm that RAD21 mutations
do indeed lead to a CdLS-like syndrome (Deardorff et al.,
2012), supporting the use of the complex map to prioritize prom-
ising candidate genes for human diseases.
Similarly, participation in the same complex suggests shared
functions; the map can thus be used to predict new biochemical
functions for proteins and other types of functions. We experi-
mentally validated one such case for a ribosome-associated
subcomplex containing BOP1, RRS1, GNL3, EBP2, FTSJ3,
and MK1671P, and we first confirmed the interactions by affinity
tagging/purification and mass spectrometry (Figure 5B). BOP1,
EBP2, and the yeast ortholog of RRS1 are known to participate
in maturation of the large 60S ribosomal subunit, suggesting
that the other factors likewise engage in ribosome assembly,
which is consistent with the nucleolar localizations of GNL3,
FTSJ3, and MKI67IP. Supporting a role in ribosome biogenesis,
short interfering RNA knockdowns of FTSJ3, MKI67IP, and, to
a lesser extent, GNL3, perturbed 60S formation in cell culture,
decreasing the ratio of free 60S to 40S subunits (Figure 5C).
Taken together, these data support roles in ribosome biogenesis
for these proteins and confirm the utility of themap for identifying
biological functions.
Conservation of Human Protein Complexes
Estimates based on sequence similarity across orthologs indi-
cate that the components of the complexes we detect are gener-
ally more ancient and have higher conservation on average
than most human proteins (Figure 6A; see Table S3 for details).
Using orthology relationships derived from well-established
sources and calculating evolutionary rates and ages for all
human proteins as a base distribution for gauging the emer-
gence of complexes (see Extended Experimental Procedures),
we found that many complexes appear to be quite ancient and
slowly evolving (Figure 6B). Strikingly, however, most (60%;
376/622) human complexes likely arose with vertebrates, i.e.,
orthologs not present in invertebrates or fungi (Table S3). Hence,
our analyses suggest a major shift/expansion in the ancestral
protein interaction network coincident with the emergence of
vertebrates.
Given the availability of experimentally derived networks of fly
and yeast protein complexes, we could directly examine the
evolutionary conservation of protein complexes across animals
by comparing our network of human complexes with the
extensive maps of 556 fly protein complexes recently reported
for D. melanogaster (Guruharsha et al., 2011) and 720 yeast
protein complexes documented for S. cerevisiae (Babu et al.,
2012). Roughly one quarter (24%; 149/622) of the predicted
human protein complexes showed statistically significant
overlaps with complexes reported for these models (Figure 6B,
inset; see Table S3 for details), with half of the subunits having
clear orthologs (Figure 6C); the remaining components presum-1076 Cell 150, 1068–1081, August 31, 2012 ª2012 Elsevier Inc.ably represent genuine differences or incomplete orthology
annotations.
The functional significance of unannotated ancestral human
complexes supported by conservation in yeast or fly (Table S3
and Figure 6) warrants further investigations. At least one such
complex, a multisubunit transfer RNA (tRNA)-splicing ligase
(Popow et al., 2011), was characterized recently. The interaction
between DDX1 and C14orf166 was detected at high confidence
both in our data set (probability score 0.899) and in the Guruhar-
sha et al. (2011) fly cocomplex data, and the other respective
associated complex subunits likewise show significant overlap
(Benjamini-corrected p value 1.1 3 107). Additional examples
of complex conservation are similarly supported by independent
experimental evidence, e.g., such as the matching tissue spec-
ificities of the putatively interacting proteins endoplasmin and
glucosidase 2b (Figure 6D), which form an uncharacterized
complex conserved in both the fly and human maps.
Functional enrichment analysis of ancient complexes in com-
parison to vertebrate-specific ones also reveals intriguing bio-
logical trends. For example, we expected ancient, core cellular
functions to be depleted among vertebrate-specific complexes.
Consistent with this expectation, we find proteins associated
with the ribosome (p% 1067, 113 proteins) andRNApolymerase
II (p% 1027, 45 proteins) to be highly enriched only among con-
served complexes. However, we also observe several notable
variations from this hypothesis. For example, compared to the
genomic background,mitochondrial proteins aremore highly en-
riched among proteins assigned to vertebrate complexes than
among those assigned to conserved complexes; 159 vertebrate
proteins have amitochondrial Gene Ontology Biological Process
(GOBP) annotation (p% 1031) versus only 81 proteins assigned
to conserved complexes (p % 105). Similarly, proteins anno-
tated as being part of the splicing apparatus are enriched in
both conserved (p % 1033; 63 proteins) and vertebrate
complexes (p % 1011, 43 proteins), which is consistent with
an ancient function gaining additional complexity in vertebrates
(e.g., increased alternative splicing). Our study therefore offers
a unique perspective into the functional conservation and diver-
sification of protein complexes across animals.
Protein Abundance, Ubiquity, and Complex Subunit
Stoichiometries
Consistent with the documented origins of the HeLa and
HEK293 cells analyzed in this study, the complexes we identified
were significantly enriched for epithelial markers (p % 10183;
UniProt tissue annotations). Explicit comparison of results
across the two cell lines used in this study provided little
evidence for tissue-specific or cell-type-specific complexes
(see Supplemental Information). Most proteins were detected
in both cell line fractionations, which is consistent with the similar
protein and mRNA expression patterns observed in these cell
lines (Figure S1), whereas the few proteins detected uniquely in
one cell line or the other did not preferentially assort into
tissue-specific complexes (Figure S2). The vast majority of
complex components are universally expressed in 11 cancer
cell lines (Geiger et al., 2012) (Figure S3A) and show high and
largely invariant expression in an mRNA sequencing (mRNA-
seq) study of 16 normal human tissues (EBI accession number
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Figure 6. Evolutionary Conservation of Protein Complexes
(A) Components of predicted human complexes—calculated as the average of evolutionary rate ratios—evolved more slowly, as compared to the entire set of
expressed proteins (see Extended Experimental Procedures).
(B) Pronounced spike in number of complexes originated with the emergence of vertebrates. x axis shows increasingly inclusive orthologous groups in the
phylogeny of eukaryotes.
(C) Human complexes conserved in fly (Guruharsha et al., 2011) and yeast (Babu et al., 2012) (see Table S3 and Extended Experimental Procedures). Nodes
represent complexes (human, blue; fly, green; yeast, orange), with size proportional to subunit number. Reciprocal best matches shown as dark gray edges, and
nonreciprocal is shown as lighter gray directed edges, with edge thickness proportional to Sorensen-Dice overlap of complex members. Human complexes
absent from public databases (putative complexes) are drawn as rectangles, and the remaining are drawn as circles.
(D) Similar tissue-specific expression patterns support a functional association between interacting proteins ENPL andGLU2B, whose orthologs were reported to
interact in fly (Guruharsha et al., 2011). Panels show representative antibody staining in normal tissue biopsies collected and reported by the Human Protein Atlas
(Uhlen et al., 2010) (www.proteinatlas.org).
See also Figure S3 and Table S3.E-MTAB-513) (Figure S3B). Indeed, complex subunits are
considered near ubiquitous (p % 1011; protein information
resource [PIR] tissue specificity annotations) and are expressed
in the top quartiles of 1,045 of 7,067 neoplastic and normal
tissue CGAP EST libraries (1% false discovery rate [FDR]),
including normal kidney (p % 1039), muscle (p % 1020), liver
(p % 1012), brain (p % 1020), vascular (p % 1030), bone
(p % 1015), and embryonic tissue (p % 1031). Consistent
with this, genes encoding complex subunits also tend to sharecommon upstream transcriptional regulatory motifs (p % 108)
(Figure 4B, inset table). Proteins mapped to complexes showed
no major bias in abundance over the complete set of human
proteins identified by mass spectrometry (Figure 1D).
The pervasiveness of ubiquitously expressed protein com-
plexes argues strongly for broad relevance to basic human cell
biology. Although often coexpressed, the subunit stoichiome-
tries of human protein complexes in vivo are largely unknown
and have never been systematically measured globally. BecauseCell 150, 1068–1081, August 31, 2012 ª2012 Elsevier Inc. 1077
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Figure 7. Protein Complex Stoichiometries
(A) Overall distribution of derived intracomplex
component stoichiometries.
(B and C) Estimated subunit stoichiometries
within and between proteins of the large and
small ribosome subunits agree on average with
the expected 1:1 ratio. Boxes summarize first
quartile, median, and third quartiles, whiskers
represent ±1.5 IQR, and circles represent outliers.
(D and E) Estimated protein subunit stoichiome-
tries within and between proteasomal pro-
teins. Intrasubunit stoichiometries within the
core, ATPase, or nonATPase regulatory subunits
agree well with the expected 1:1 ratio, but
stoichiometries observed between these com-
plexes deviate significantly from 1:1 (ATPase:non-
ATPase, Mann-Whitney p % 103; core:ATPase,
p% 1012; core:non-ATPase, p% 1016).
See also Table S2.all reconstructed complexes are supported by the same set of
extensive experimental mass spectrometry data, we could esti-
mate subunit stoichiometries based on the ratios of recorded
spectral counts after correcting appropriately for protein size
and composition (see Extended Experimental Procedures).
Although only approximate ratios were inferred and peaked at
1:1 (Figure 7A), such as between known ribosomal subunits
(Figures 7B and 7C), the results highlight intriguing deviations
in subunit abundance (Table S2). An example drawn from the
proteasome is illustrative: whereas the median stoichiometry of1078 Cell 150, 1068–1081, August 31, 2012 ª2012 Elsevier Inc.core a and b enzymatic subunits is close
to the expected 1:1 ratio, the median of
stoichiometries of core to non-ATPase
regulatory subunits deviated significantly
at 4:1 (Mann-Whitney p % 1016; Fig-
ures 7D and 7E). Hence, these data
suggest a rich source of information
about the physical organization of human
proteins.
DISCUSSION
The biochemically based interaction data
obtained in this integrative proteomic
study have enabled the identification of
both 364 previously unannotated protein
complexes (i.e., predicted complexes
with no statistically significant match to
complexes in public databases) encom-
passing 1,278 human proteins, many of
which are linked to human disease, and
unexpected components and interac-
tions for well-studied, widely conserved
nuclear and cytoplasmic protein machin-
eries, such as ribosome biogenesis,
with clear biological implications. Most
of the high-confidence protein interac-
tions provided in this resource have notbeen previously reported in public interaction databases and
hence motivate mechanistic investigations of specific biological
systems.
Prior to this work, experimental knowledge regarding soluble
protein complex membership in human cells has generally
been ad hoc or focused on specific subcellular systems. Our
relatively unbiased integrative approach, wherein biochemical
evidence (cofractionation) of soluble native macromolecules
was combined with genomic inferences (imputed functional
associations), provides an inclusive snapshot of human protein
complexes present under a standardized cellular context, thus
serving as a reference against which future process- or cell-
type-specific or dynamic interaction data sets can be compared.
Information gleaned from orthology proved to be an important
resource in separating true pairwise interactions from putative
false positives and, in turn, could reasonably be expected to
bias our results toward conserved complexes. In fact, although
we do find conserved complexes as expected, we also find
a majority that are not conserved (in fly and yeast) and that
seemingly have arisen with vertebrates (i.e., Figure 6B). The
slower rate of evolution of the subunits we report for our protein
complexes is also a feature of other human PPI networks, such
as in CORUM, and thus, our predictions of broad complex
conservation, albeit incomplete, are not just artifacts of our
methodology.
The fact that we detected little evidence of tissue specificity for
most of the derived human protein complexes and few cell-type-
specific components likely reflects undersampling by our mass
spectrometry procedures, which is a common limitation of LC-
MS/MS. At the level of predicted PPI (which are derived from
multiple biochemical fractions), differences in the proteomic
profiles generated for the two cell lines lie within the variance
observed between biological replicates of the same cell line
(Figures S1 and S2). Yet it is clear that differential interactomes
and the contextual rewiring of PPI networks are major determi-
nants of cell behavior and phenotypes. The complexes we report
undoubtedly undergo differential rewiring in response to environ-
mental, physiological, developmental, or disease states. With
further refinements to our experimental procedures, our interac-
tion mapping strategy has the potential to interrogate changes in
interaction space in a systematic manner in the future.
To enable exploitation of these data by the scientific
community, we have generated a dedicated web database of
human protein complexes (http://human.med.utoronto.ca) that
contains all the data generated in this study in an easily navi-
gated format. These include all of the supporting information
for each of the pairwise protein interactions obtained through
integration of our cofractionation data with public genomic
evidence, a list of the 5,584 proteins detected in each of the
1,163 biochemical fractions collected, and the subunit composi-
tion of the 622 putative protein complexes obtained through
clustering of our generated high-confidence interaction network.
This ‘‘first pass’’ draft of the soluble, stably associated human
protein ‘‘complexome’’ provides a glimpse into the global phys-
ical molecular organization of human cells, which is likely to be
perturbed in pathological states.EXPERIMENTAL PROCEDURES
Cell Culture and Extract Preparation
HeLa S3 (ATCC#: CCL-2.2) and HEK293 (ATCC#: CRL-1573) soluble nuclear
and cytoplasmic protein extracts were prepared by conventional methods
(see Extended Experimental Procedures). Prior to fractionation, lysates were
treated with 100 units/ml Benzonase (Novagen Inc.) to remove nucleic acids
and clarified by centrifugation to remove debris.
Biochemical Fractionation and Proteomic Analysis
We performed weak anion-exchange and mixed-bed ion exchange, both with
and without a heparin precolumn to enrich for nucleic-acid-binding proteins.In total, 1,095 chromatography fractions were collected (see Extended Exper-
imental Procedures). Isoelectric focusing was carried out on a MicroRotofor
Liquid-Phase IEF cell (Bio-Rad) according to the manufacturer’s protocol,
with 40 fractions collected across a pH range. Sucrose density gradient centri-
fugation was performed as previously described (Ramani et al., 2008), with 28
fractions collected.
Proteins were acid precipitated and trypsin digested, and the peptide
mixtures were fractionated and sequenced by using nanoflow liquid chroma-
tography-electrospray tandemmass spectrometry. Spectra were collected on
an LTQ linear ion trap (ThermoFisher Scientific) (majority) or LTQ Orbitrap
Velos hybrid mass spectrometer and searched against a UniProt human
target-decoy sequence database by using SEQUEST (Eng et al., 2008) (see
Extended Experimental Procedures). The LC-MS/MS identifications were
filtered to a 1.0% protein and peptide theoretical FDR.
Bioinformatics Analyses
Protein cofractionation networks were scored by correlation analysis (Pearson
correlation, weighted cross-correlation, coapex) based on the protein spectral
counts recorded across each set of fractions (see Extended Experimental
Procedures). Weighted networks were likewise constructed based on func-
tional evidence reported in HumanNet (Lee et al., 2011), omitting human
protein interaction data to minimize circularity that might bias our association
predictions. A coevolution network (Tillier and Charlebois, 2009) based on
correlated evolutionary rates was built to account for additional associations
not covered in HumanNet.
For the machine-learning classifier, we used the fast random forest imple-
mentation in Weka (see Extended Experimental Procedures) to integrate all
generated networks. Cross-validated decision trees were learned and bench-
marked by using independent training and test sets of CORUM reference
complexes (Ruepp et al., 2010). We denoised the network by using a diffusion
procedure to delete interactions lacking network topology support and by
calibrating the diffused interaction scores with Gene Ontology (Cellular
Component) normalized semantic similarity scores (see Extended Experi-
mental Procedures).
Clusters were defined by using the ClusterONE algorithm with parameter
settings chosen to yield the highest maximum matching ratio (Nepusz et al.,
2012) between the predicted complexes and set of cluster-training complexes
(see Extended Experimental Procedures).
Stoichiometries calculation is shown in Extended Experimental Procedures.
ACCESSION NUMBERS
The interaction data have been deposited into BioGRID and are also publicly
accessible via a dedicated web portal (http://human.med.utoronto.ca/).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and six tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2012.08.011.
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